| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2591 |
| Trial ID | NCT04745559 |
| Disease | Primary Mediastinal B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma | High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit | Follicular Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | Pneumococcal 13-valent Conjugate Vaccine |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy |
| Year | 2021 |
| Country | United States |
| Company sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Other ID(s) | MCC-20571 |
| Cohort 1 | |||||||
|
|||||||